AN2 Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
AN2 Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2022 to Q4 2022.
  • AN2 Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $20K.
  • AN2 Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2022 was $80K.
  • AN2 Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $50K, a 37.5% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $80K $20K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $20K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $20K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $20K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.